Previous reports demonstrated that repeated administration of peroxisome proliferators protects against acetaminophen (APAP) hepatotoxicity in mice. This protection was associated with a decrease in APAP's selective protein arylation and glutathione depletion. This study was conducted to determine if a single dose of clofibrate (CFB), rather than repeated doses, would similarly prevent APAP toxicity. CD-I male mice received a single dose of 500 mg CFB/kg and controls were given corn oil 24 hr prior to APAP challenge. After an 18-hr fast, mice were challenged with 800 mg APAP/kg (in 50% propylene glycol) and killed at 4 or 12 hr. Other mice similarly pretreated were killed without APAP challenge. The results showed that pretreatment with a single CFB dose significantly decreased APAP-induced hepatotoxicity. At 12 hr after APAP plasma sorbitol dehydrogenase activity and the severity of hepatocellular necrosis were decreased in CFB pretreated mice. Surprisingly, no differences in hepatic nonprotein sulfhydryl (NPSH) depletion or selective arylation of target proteins in cytosol were observed at 4 hr after APAP challenge. Neither did a single dose of CFB significantly alter hepatic NPSH content prior to APAP challenge. These results indicate that protection against APAP hepatotoxicity by CFB does not require repeated administration, and the absence of significant alterations in APAP's selective protein arylation or glutathione depletion suggests that the protection against APAP hepatotoxicity after a single treatment with CFB may differ mechanistically from the protection observed 
. This toxicity greatly depends on the extent of APAP bioactivation to the reactive intermediate /V-acetyl-p-benzoquinoneimine (NAPQI) by CYP450 (Mitchell et al, 1973a; Dahlin et al, 1984) . Experimental paradigms that alter APAP bioactivation, detoxification and cellular glutathione status have been employed to modulate the severity of APAP toxicity. For example, hepatotoxicity was decreased by inhibiting or increased by inducing CYP450 (Mitchell et al, 1973a) , and administration of Nacetyl-L-cysteine, which replenishes hepatic glutathione (GSH), has been used to ameliorate APAP toxicity (Prescott and Critchley, 1983; Mitchell et al, 1973b) . In addition, increasing APAP's detoxification through conjugation with glucuronic acid by treatment with butylated hydroxyanisole, pregnenolone-16a-carbonitrile, oltipraz, or oleanolic acid protects against APAP hepatotoxicity (Hazelton et al, 1896; Madhu and Klaassen, 1991; Davies et al, 1991; Liu et al, 1993) .
Clofibrate [2-(p>-chlorophenoxy)-2-methyl-propionic acid ethyl ester](CFB) is a hypolipidemic drug also known to induce proliferation of hepatic peroxisomes (Lock et al, 1989) . This effect has been associated with the development of hepatocellular carcinomas primarily in rodents (Reddy and Lalwani, 1983; Conway et al, 1989; Moody et al, 1991) . Recently, repeated dosing with peroxisome proliferators has been shown to protect against APAP hepatotoxicity (Nicholls-Grzemski et al, 1992; Manautou et al, 1994a) . Mice receiving CFB for 10 days prior to a normally hepatotoxic APAP challenge showed no elevation in plasma sorbitol dehydrogenase (SDH) activity or histopathology. Hepatic GSH and selective arylation of the major APAP target proteins were also markedly decreased in the CFB-treated animals challenged with APAP. This suggested that the CFB protection resulted from decreased availability of NAPQI. However, no differences in APAP bioactivation, glutathione •S-transferase activity, or APAP glucuronidation were detected in livers from CFB-pretreated mice (Manautou et al, 1994a,b) . Notably, hepatic glutathione content was significantly increased by the CFB pretreatment and may be responsible for the protection against APAP toxicity (Manau-tou etal, 1994a) . This likely contributed to CFB's protection from APAP covalent binding and toxicity since there was a correlated early increase in biliary clearance of APAP-GSH conjugates in CFB-treated mice (Manautou et al., 1994b) .
Although 10 days of CFB pretreatment was employed in the cited protection against APAP toxicity. peroxisome proliferators generally produce hepatocellular changes after shorter treatment regimens (Reddy and Lalwani, 1983; Berman et al., 1983) . Therefore, it was of interest to determine if multiple days of CFB dosing was a prerequisite to the protection from APAP covalent binding and toxicity, or whether a single CFB pretreatment could similarly protect. The present study demonstrates that a single CFB pretreatment diminished APAP toxicity in the CD-I mice; however, by contrast with the protection noted with multiple CFB treatments, this protection was not accompanied by a corresponding diminution of APAP covalent binding.
MATERIALS AND METHODS

Reagents.
4-Acetamidophenol (APAP), clofibrate, Folin reagent, glutathione, 5,5'-dithiobis(2-nitrobenzoic acid), Tnzma hydrochlonde, ponceau S, sorbitol dehydrogenase, teleostean (fish) gelatin, phenylmethylsulfonyl fluoride, and anti-rabbit IgG peroxidase conjugates were obtained from Sigma Chemical Co. (St. Louis, MO). Acrylamide (electrophoretic grade) and Coomassie brilliant blue were obtained from Boehringer Mannheim Biochemicals (Indianapolis, IN) and Bio-Rad Laboratories (Richmond, CA), respectively. All other chemical and biochemical reagents were obtained from the above suppliers and were of reagent grade or better.
Animals.
Three-month-old male Crl:CD-1(ICR)BR mice (Charles Rivers Laboratories, Wilmington, MA) were housed in community stainless steel cages above hardwood chips (Sani-Chips, P. J. Murphey Forest Products, Montville, NJ) with free access to Laboratory Rodent Diet 5001 (PMI Feeds, Inc., St. Louis, MO) and water Lights were maintained on a 12:12-hr hght:dark cycle, and the room temperature was maintained at 22°C.
Treatment regimen.
Mice received a single dose of either corn oil vehicle (5 ml/kg) or 500 mg CFB/kg in corn oil, lp, 24 hr before APAP challenge (Nicholls-Grzemski et al., 1992) . They were fasted 18 hr prior to challenge with 800 mg APAP/kg (in 50% propylene glycol/water) by gavage and were killed by decapitation 4 or 12 hr later. Controls were given vehicle only. Other mice were similarly treated with CFB but were killed without either APAP or vehicle challenge
Evaluation of APAP-induced hepatotoxicity.
Trunk blood from mice killed 12 hr after APAP challenge was collected into heparinized microcentrifuge tubes and the plasma was separated by centrifugation. Plasma SDH activity was measured as an indicator of hepatocellular necrosis by the method of Gerlach and Hiby (1971) . with modifications for a 96-well microplate assay as described (Manautou et al.. 1994a) .
For histopathology. sections of livers were collected from mice killed 12 hr after APAP and stored in 10% neutral-buffered formalin. Fixed sections were embedded in paraffin, sectioned at 5 nm and stained with hematoxyhn and eosin. Livers were examined by light microscopy for evidence of hepatocellular necrosis which was graded on a scale of 0-5 (0 = no lesions; 1 = minimal lesions, process involves less than 10% of the tissue: 2 = mild lesions, 10-25%: 3 = moderate lesions. 25-50%: 4 = marked lesions. 50-90%; 5 = severe lesions, more than 90%). Liver sections with scores higher than 2 were considered to exhibit significant hepatocellular necrosis as previously described (Bartolone et al.. 1989a) . Data from animals that died prior to 12 hr were not included.
Liver nonprotein sulfhydryl (NPSH) content was measured as an indicator of GSH using the colonmetnc assay of Ellman (1959) . Liver samples were obtained from mice killed without APAP challenge or at 4 and 12 hr after APAP. Liver homogenates (20% w/v) were prepared in 5% trichloroacetic acid/ethylenediaminetetraacetic acid buffer and centrifuged at 1500g for 15 rrun. Ahquots of supernatants were assayed in 96-well microplates using a CERES UV 900 HDi Workstation (Bio-Tek Instruments, Inc., Winooski, VT) as previously described (Manautou et al., 1994a) .
Immunochemical assessment of APAP selective covalent binding. Li vers from mice killed 4 hr after APAP were immediately excised and homogenized (10% w/v) in a buffer consisting of 0.25 M sucrose, 10 HIM Tris-HCI, 1 HIM MgCl 2 . pH 7.4 (STM buffer). Homogenates were centnfuged at 9000g in a J2-21 centrifuge (Beckman Instruments, Palo Alto, CA) for 20 min at 4°C. The resulting supernatant was then centnfuged at 105,000g for 60 min in a Beckman L7-55 ultracentnfuge. Cytosolic fractions were collected and stored (-70°C) until assayed. Total protein concentration in cytosol was determined by the procedure of Lowry et al. (1951) . APAP binding was determined by immunoassays. Briefly, proteins (30 /xg/lane) were resolved on discontinuous 10% SDS-PAGE slab gels using a 3% stacking gel as described by Laemmli (1970) . Resolved proteins were transblotted onto Immobilon-P PVDF transfer membrane (Millipore Corp., Bedford, MA). APAP-bound proteins were analyzed by immunostaining with affinity-purified anti-APAP antibody (Bartolone et al., 1988; Birge et al., 1989) followed with peroxidase-conjugated anti-rabbit IgG. Immunoreactive proteins were detected using ECL Western blotting detection reagents (Amersham Life Science, Arlington Heights, IL) and visualized by exposure of Kodak XAR-5 film. Immunoreactive intensity of Western blots was quantified using a PDI Image Analyzer (Protein and DNA imageWare Systems, Huntington Station, NY).
Statistical Analysis. Results are expressed as means ± SE. Except as indicated, groups of at least five mice were used in all studies. Data were analyzed using a one-way analysis of variance (ANOVA) followed by Duncan's new multiple range test. The Student's t test was employed to determine statistical differences between two means. The raw histopathology scores were analyzed using the Kruskal-Walhs Nonparametric AN- Note. Male CD-I mice were pretreated with a single dose of CFB (500 mg/kg, ip) or com oil vehicle (CO). After overnight fast, they were challenged with 800 mg APAP/kg or 50% propylene glycol vehicle (PG). Animals were killed and livers were collected 12 hr later and examined histologically for incidence and severity of hepatocellular necrosis. Sections of livers were graded depending on the extent of necrosis from 0 to 5 as described under Materials and Methods. Scores higher than 2 were considered indicative of significant hepatocellular necrosis. No histopathology scores were tabulated for animals which died prior to 12 hr.
OVA (Statistica, StatSoft, Tulsa, OK). When a significant difference between at least two groups was detected, the scores were converted to ranks and were subjected to one-way ANOVA. Differences between treatments were determined by Duncan's new multiple range test. For all statistical analyses, differences were considered significant at p =s 0.05.
RESULTS
Effect of CFB on APAP hepatotoxicity.
A single dose of 500 mg CFB/kg 24 hr prior to challenge with 800 mg APAP/kg provided partial protection against hepatotoxicity. At 12 hr after APAP, plasma SDH activity was approximately 3500 U/liter in corn oil-pretreated mice which is indicative of significant hepatocellular necrosis (Fig. 1 ). This enzyme activity was significantly lower (approximately 1500 U/liter) in mice given a single dose of CFB 24 hr prior to APAP challenge. This represents a 40% reduction in enzyme leakage. Mice given either a single dose of corn oil or CFB and challenged with propylene glycol vehicle (controls) had plasma SDH activity less than 50 U/liter. APAP challenge caused 38% mortality in the corn oilpretreated group but no mortality in the CFB-pretreated mice (Table 1) . Histopathologic evaluation of liver sections (Table  1) supports the SDH data. After APAP challenge, 50% of corn oil-pretreated mice (f) had pathology scores higher than 2. This has traditionally been accepted as evidence of APAPinduced hepatic damage in the CD-I mouse model (Bartolone et al., 1989a; Emeigh Hart et al, 1994; Manautou et al., 1994a) . By contrast, only 10% of the CFB-pretreated mice (jo) showed similar damage, demonstrating that a single dose of CFB decreased APAP hepatotoxicity. Representative severity of lesions detected is depicted in Fig. 2 . In corn oilpretreated mice challenged with APAP, moderate to severe hepatic centrilobular necrosis was detected (Fig. 2a) . This was generally decreased in CFB-pretreated mice given the same APAP challenge (Fig. 2b) . Figs. 2c and 2d depict representative sections of liver from, respectively, corn oiland CFB-pretreated mice challenged with propylene glycol vehicle, and they are shown for comparison. In agreement with previous reports in rats (Berman et al., 1983) , mild centrilobular hepatocellular hypertrophy was detected in both groups of CFB-pretreated mice (Figs. 2b and 2d) .
Effect of CFB on hepatic NPSH before and after APAP challenge. When mice were dosed with 500 mg CFB/kg and killed after overnight fast without any challenge, hepatic NPSH content was not significantly different from that of vehicle controls (p = 0.37) (Fig. 3a) . Other similarly pretreated mice were challenged with 800 mg APAP/kg. At 4 hr after APAP challenge, hepatic NPSH levels were similarly depleted in corn oil-and CFB-pretreated mice to approximately 10-20% of the levels in vehicle controls (Fig. 3b) . By 12 hr after APAP, mice pretreated with CFB had NPSH values similar to control (95%), whereas in corn oil-pretreated mice these values had returned to only 60% of control levels (Fig. 3c) .
Immunochemical analysis of APAP selective binding to hepatic cytosolic proteins. The effect of CFB pretreatment FIG. 2 . Effect of CFB pretreatment on liver histopathology in mice challenged with APAP. CFB (500 mg/kg)-or com oil vehicle (5 ml/kg)-pretreated mice were killed at 12 hr after APAP challenge (800 mg/kg). Sections of livers were obtained and processed for histopathological evaluation as described under Materials and Methods. Representative photomicrographs (original magnification 4616X; stain, hematoxilin and eosin) from each treatment group are presented as follows: (a) Liver section from mice pretreated with com oil vehicle and challenged with 800 mg APAP/kg. Note presence of extensive centrilobular necrosis (arrow), (b) Liver section from mice pretreated with CFB and challenged with APAP. Note that the severity of hepatocellular necrosis is much less than in a. Also note the presence of hepatocellular hypertrophy in adjacent unaffected centrilobular hepatocytes (open arrow), (c) Liver section from mice pretreated with com oil vehicle and challenged with 50% propylene glycol vehicle, for comparison, (d) Liver section from mice pretreated with CFB and challenged with 50% propylene glycol, also for comparison. Note the presence of enlarged (hypertrophied) centrilobular hepatocytes (arrow; compare to c). on APAP selective protein arylation was determined at 4 hr after APAP dosing. Figure 4 shows the Western blot analysis of liver cytosol from individual control and CFB-pretreated mice challenged with APAP. In the corn oil-APAP group the most prominent arylation was to cytosolic proteins of 58, 56, and 44 kDa. In the CFB-APAP group there was similar binding to the same target proteins, suggesting that pretreatment with a single dose of CFB had no significant effect on the extent of selective covalent binding to cytosolic target proteins. This was verified by quantitative image analysis (Fig. 5) .
DISCUSSION
Previous studies showed that repeated dosing for 10 days with CFB protected against APAP toxicity (NichollsGrzemski et al., 1992; Manautou et al., 1994a) . Selective arylation to all cytosolic and microsomal hepatic proteins and NPSH depletion after similar APAP challenge were significantly reduced in mice pretreated with CFB for 10 days (Manautou et al., 1994a) . Such findings are indicative of there being diminished electrophile available to interact with critical cellular targets. In that study, mice pretreated with CFB had significantly higher levels of hepatic GSH (Manautou et al., 1994a) . This led to the suggestion that the lack of APAP toxicity in the multidose CFB-pretreated mice involved detoxification of the reactive intermediate by conjugation with GSH.
The current study addresses the question of whether a single dose of CFB could also reduce the severity of APAPinduced hepatotoxicity in the CD-I mouse model. As with the multidose CFB regimen, a single dose of CFB also protected against APAP toxicity. However, in contrast to protection with the multidose CFB regimen (Manautou et al., 1994a) , which was associated with significant decreases in APAP's protein arylation and GSH depletion, the single dose CFB protection did not significantly alter these APAP actions. It must be noted that the statistical analysis of the histopathology scores from APAP-challenged mice data did not reveal a significant difference between the corn oil and CFB pretreatments (p = 0.07). However, the histopathology scores and SDH data analyzed did not include mice which mw(kDa) co/pq co/apap cfb/ apap   FIG. 4 . Effect of CFB pretreatment on APAP selective arylation of cytosolic proteins. Mice were pretreated with a single dose of CFB (500 mg/kg) or corn oil vehicle (5 ml/kg) and killed at 4 hr after challenge with 800 mg APAP/kg in 50% propylene glycol (pg) vehicle. Hepatic cytosolic fractions were obtained as described under Materials and Methods. APAP covalent binding in cytosol, from at least five mice per group, was evaluated immunochemically by Western blotting (30 /xg/lane) using an affinity-purified anti-APAP antibody co/pg, corn oil-pretreated, propylene glycol vehicle challenged mouse; co/apap, corn oil-pretreated, APAP-challenged mice; cfb/apap, clofibrate-pretreated, APAP-challenged mice. The most prominent target proteins (58, 56, and 44 kDa) are indicated by arrows on the right died prior to the scheduled 12-hr time point. Since deaths occurred only in the corn oil-pretreatment group, this may have removed several necrotic livers from the count and thus weakened the data statistically. Based upon the traditional acceptance of scores greater than 2 as evidence of APAPinduced hepatic damage in the CD-I mouse model (Bartolone et al, 1989a; Emeigh Hart et al., 1994; Manautou et al., 1994a) , these histopathology findings are in general agreement with SDH and mortality data and strongly suggest that CFB protected against APAP-induced hepatotoxicity. At 12 hr after APAP, hepatic NPSH had returned to control levels in the CFB-pretreated mice while this did not occur in the APAP-challenged controls. This further documents the protective action of CFB against APAP toxicity, since NPSH repletion occurs more rapidly with APAP treatments which do not result in hepatic toxicity than it does when hepatotoxicity occurs (Placke et al., 1987) .
In the present study, the single dose of CFB did not alter hepatic NPSH levels, nor did it change the degree of NPSH depletion after APAP challenge. Neither were there any readily discernible CFB-induced differences in the pattern or amount of APAP covalent binding to liver cytosolic proteins. This suggests that the amount of available APAP electrophile was not altered by the single CFB pretreatment. Thus, if one assumes that the extent of protein covalent binding reflects the net result of activation and detoxification pathways it seems unlikely that CFB protection resulted from effects on APAP metabolism. However, it remains possible that small differences in the rate of NAPQI formation might have occurred, contributing to the protection by CFB. Such subtle differences would have been difficult to determine with the immunoblotting and image analysis techniques used to quantify APAP's protein arylation.
Immunochemical analysis of protein arylation with the anti-APAP antibody revealed animal to animal variability in binding to target proteins in liver cytosol regardless of the pretreatment. This is consistent with earlier observations (Manautou et al., 1994a) . It is of interest that these mice also vary in their expression of the 58-ABP in liver cytosol (Manautou et al., 1994a) and, generally, APAP arylation of this protein correlates with 58-ABP content. Thus, when 58-ABP content is low other cytosolic proteins are more prominently targeted (Hoivik et al., 1995; unpublished observations) . Conversely, with higher 58-ABP content, APAP arylation of 58-ABP is most prominent relative to targeting of other cytosolic proteins. It would be interesting to determine if the early level of APAP arylation correlated with the degree of toxicity in individual mice. However, at present such determinations cannot easily be conducted. By the time toxicity is readily described biochemically and histopathologically, e.g., at 12 hr, the level of covalent binding may differ significantly from that which occurred early after APAP dosing and which more likely is associated with initiating events. Concomitant measurement of covalent binding in such studies at 12 hr after APAP would not be helpful since loss of arylated proteins has been readily demonstrated at later time points after APAP treatment (Bartolone et al., 1989b; Pumford et al., 1990; Roberts et al., 1991) .
Multiple mechanisms have been postulated to explain why pretreatment with some xenobiotics confers "resistance" against cytotoxic effects of other chemicals. Alterations in drug metabolism, especially detoxification pathways, are often associated with this phenomenon. More recent evidence (Fig. 4) were subjected to image analysis using a PDI Image analyzer. Results represent the means ± SE of the relative optical density values (OD x mm) of the most prominent target proteins (58, 56, and 44 kDa) for each treatment group. There was no significant CFB effect for binding to any of the indicated protein bands (n = 5-6).
suggests that induction of processes associated with hepatocellular regeneration as a result of the initial toxicant insult may confer protection against a subsequent toxic challenge with the same compound or a different one (Thakore and Mehendale, 1991; Chanda and Mehendale, 1993) . Since it is well established that CFB dosing induces liver hyperplasia (see reviews by Lock et al., 1989; Moody et al., 1991) , it is possible that this hepatocellular proliferation induced by CFB involves events similar to those of the regeneration described by Mehendale and co-workers (Thakore and Mehendale, 1991; Chanda and Mehendale, 1993) and thereby protects against toxicity by similar mechanisms.
Amelioration of APAP toxicity without changes in covalent binding has been previously demonstrated. Compounds such as yV-acetyl-L-cysteine, when given after APAP challenge, reduced APAP toxicity without producing significant changes in total hepatic covalent binding (Gerber et al., 1977) . Also, mice given the sulfhydryl compound a-mercaptopropionylglycine showed a marked decrease in APAP-induced hepatotoxicity without changes in total covalent binding (Labaderios et al., 1977) . More recent studies have shown that alterations in the severity of hepatocellular damage are better associated with changes in selective protein arylation rather than with total covalent binding. Beierschmitt et al. (1989) demonstrated that 3-month-old mice were more sensitive to APAP hepatotoxicity than 2-monthold mice. Although the amount of covalently bound [
3 H]-APAP in liver was similar in both age groups, immunochemical analysis of selective protein binding revealed distinct differences in binding patterns. Also, the administration of piperonyl butoxide 2 hr after APAP reduced the severity of hepatic injury in mice. This protection was associated with changes in selective APAP binding without alterations in total covalent binding (Brady et al., 1990) . By contrast, in the present study, the CFB-induced protection occurred in the absence of alterations in APAP binding to the most prominent protein targets. This suggests that the CFB protection may have involved a postarylative intervention in the progression phase of toxicity.
The initiating events in APAP hepatotoxicity occur subsequently to NAPQI formation and glutathione depletion. The covalent binding which ensues has been deemed necessary but not sufficient for toxicity, and oxidative stress has been suggested as contributing significantly to the cellular damage (see review by Vermeulen et al., 1992) . It has been suggested that oxidative events occur later in the progression of APAP toxicity, i.e.. subsequent to the initial covalent binding (Jaescke, 1990 ). Furthermore, the antioxidants diphenyl-p-phenylenediamine and 3-0-methyl(+)catechin decreased the severity of APAP toxicity, in vitro, in the absence of alterations in total covalent binding or GSH depletion (Devalia et al., 1982; Harman, 1985) . Peroxisome proliferators can also protect against oxidative insult. Garberg et al. (1992) showed that primary hepatocytes in culture isolated from nafenopintreated rats were more resistant to hydrogen peroxide toxicity. Thus, it is possible that CFB's postarylative protection against APAP toxicity might similarly involve protection against the later, oxidative component of APAP toxicity. Additional studies are needed to test this.
Overall, the present findings demonstrate that changes produced by CFB affording resistance against APAP hepatotoxicity occurred relatively fast and do not required repeated CFB administration. Furthermore, single versus multidose CFB protection (Manautou et al., 1994a ) most likely involves different mechanisms since the previously reported multidose protection was associated with diminished protein arylation, whereas the single-dose CFB protection was not. These findings provide further support to the concept of APAP hepatotoxicity viewed as a sequence of events which begin with electrophile generation and interaction (e.g., covalent binding) within the cell. Protection can occur by preventing such interactions or by other intervening effects at later times in the progression of toxicity.
